Antibodies targeting a shared epitope exploit IgE allostery to drive distinct functional outcomes
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2613091123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Anna M Davies und 8 weiteren Autor:innen. Beteiligte Einrichtung: Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom. Hauptthemen laut MEDLINE: Immunoglobulin E, Epitopes. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UKRI | Medical Research Council (MRC).
Abstract (Originalsprache)
The Fc region of immunoglobulin E (IgE-Fc) is an important therapeutic target due to the antibody’s critical role in allergic disorders through interactions with high-affinity (FcεRI) and low-affinity (CD23) receptors. IgE-Fc is known to be conformationally flexible, undergoing large-scale structural changes that modulate receptor binding and downstream biological functions. The mechanistic basis for how ligands induce these allosteric changes is not fully understood. In this study, we investigate structure–function relationships of IgE by characterizing four closely related anti-IgE-Fc Fab fragments with highly conserved sequences that recognize a shared epitope at the base of the Cε2 domain. Despite their sequence similarity, these Fabs exhibit markedly different binding characteristics, stoichiometries, and functional activities. Furthermore, the crystal structures of these four Fab complexes reveal that the bound IgE-Fc adopts a wide range of conformations. These structural differences directly dictate the functional outcomes, ranging from conformations that facilitate FcεRI binding to those that prevent or destabilize receptor interaction. Our findings demonstrate that highly similar antibodies binding to the same epitope on a protein that exhibits significant conformational plasticity can elicit distinct and divergent functional outcomes. This work challenges the conventional antibody discovery paradigm, i.e., “same epitope, same functional outcome,” and highlights the importance of accounting for both the target’s structural flexibility and the resulting functional diversity within antibody selection strategies. This is especially critical when targeting dynamic proteins where allosteric mechanisms are fundamental to function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.
- UCB, Slough SL1 3WE, United Kingdom.
ORCID-Profile: Anna M Davies, Andrew J Beavil, Tom Ceska, Brian J Sutton, James M McDonnell
Förderung
- Wellcome Trust
- UKRI | Medical Research Council (MRC)
Zitieren
APA
Davies, A. M., Drinkwater, N., Beavil, A. J., O'Dowd, V., Lightwood, D., Ceska, T., Henry, A. J., Sutton, B. J., & McDonnell, J. M. (2026). Antibodies targeting a shared epitope exploit IgE allostery to drive distinct functional outcomes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2613091123
Vancouver
Davies AM, Drinkwater N, Beavil AJ, O'Dowd V, Lightwood D, Ceska T, et al. Antibodies targeting a shared epitope exploit IgE allostery to drive distinct functional outcomes. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2613091123
BibTeX
@article{Davies2026,
author = {Davies, Anna M and Drinkwater, Nyssa and Beavil, Andrew J and O'Dowd, Victoria and Lightwood, Daniel and Ceska, Tom and Henry, Alistair J and Sutton, Brian J and McDonnell, James M},
title = {Antibodies targeting a shared epitope exploit IgE allostery to drive distinct functional outcomes},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2613091123}
}
EUVIMED